PAVmed (PAVM) Receivables - Other (2016 - 2021)
PAVmed (PAVM) posted quarterly Receivables - Other of $27000.0 for Q1 2021, up 8.0% quarter-over-quarter from $25000.0 in Q1 2016.
PAVmed (PAVM) Receivables - Other (2016 - 2021) Analysis & Trends
PAVmed's Receivables - Other history runs 2 years deep, the most recent figure standing at $27000.0 for Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | PAVmed | 32.79 Mn | 29.00 Mn | -89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 27,000.00 |
| Mar 31, 2021 | 27,000.00 |
| Mar 31, 2016 | 25,000.00 |
| Mar 31, 2016 | 25,000.00 |